Results
Mankind Pharma Q4 Net Profit Rises to ₹713.61 Crore
Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reporting ₹713.61 crore quarterly net profit.
Approved ₹500 crore additional investment in whol
